Uric acid and neurodegenerative diseases: finding a predictor of cognitive decline
Ácido úrico y enfermedades neurodegenerativas: encontrando un predictor del deterioro cognitivo | 尿酸与神经退行性疾病：寻找认知衰退的预测指标
DOI:
https://doi.org/10.25176/RFMH.v24i3.6639Abstract
Uric Acid, a potent endogenous antioxidant, has recently been investigated for its potential relationship with neurodegenerative diseases. This letter proposes that uric acid could serve as a predictive marker of cognitive decline in neurodegenerative conditions. Recent studies suggesting a correlation between elevated uric acid levels and a lower risk of cognitive decline are reviewed, advocating for further research to confirm these findings. Additionally, the clinical implications of using uric acid as a potential biomarker in neurological practice are discussed.
Downloads
References
Alzheimer's Disease International. World Alzheimer Report 2019: Attitudes to
Dementia. A global Survey. https://doi.org/10.1002/alz.038255
Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz
K, et al. Projected number of people with Parkinson disease in the most populous
nations, 2005 through 2030. Neurology. 2007;68(5):384-6.
https://doi.org/10.1212/01.wnl.0000247740.47667.03
Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR,
Zoing MC. Amyotrophic lateral sclerosis. Lancet. 2011 Mar 12;377(9769):942-55.
doi: 10.1016/S0140-6736(10)61156-7. Epub 2011 Feb 4. PMID: 21296405.
Bowman GL, Shannon J, Frei B, Kaye JA, Quinn JF. El ácido úrico como
antioxidante del SNC. J Alzheimers Dis. 2010; 19(4):1331-6. doi: 10.3233/JAD-
-1330. PMID: 20061611; PMCID: PMC2859185.
Boccardi V, ReGAl 2.0 Study Group:, Carino S, Marinelli E, Lapenna M, Caironi
G, et al. Uric acid and late-onset Alzheimer’s disease: results from the ReGAl 2.0
project. Aging Clin Exp Res [Internet]. 2021;33(2):361–6. Disponible en:
http://dx.doi.org/10.1007/s40520-020-01541-z
Lee Y-G, Park M, Jeong SH, Kang SW, Baik K, Jung JH, et al. Effects of baseline
serum uric acid and apolipoprotein E4 on longitudinal cognition and cerebral
metabolism. Neurobiol Aging [Internet]. 2021 [citado el 15 de abril de
;106:223–31. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34311431/
Shi X, Zheng J, Ma J, Wang Z, Sun W, Li M, et al. Low serum uric acid levels are
associated with the nonmotor symptoms and brain gray matter volume in
Parkinson’s disease. Neurol Sci [Internet]. 2022 [citado el 8 de abril de
;43(3):1747–54. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34405296/
Aerqin Q, Jia S-S, Shen X-N, Li Q, Chen K-L, Ou Y-N, et al. Serum uric acid
levels in neurodegenerative disorders: A cross-sectional study. J Alzheimers Dis
[Internet]. 2022 [citado el 8 de abril de 2024];90(2):761–73. Disponible en:
https://pubmed.ncbi.nlm.nih.gov/36189590/
Iazzolino B, Grassano M, Moglia C, Canosa A, Manera U, Vasta R, et al. High
serum uric acid levels are protective against cognitive impairment in amyotrophic
lateral sclerosis. J Neurol [Internet]. 2024 [citado el 8 de abril de
;271(2):955–61. Disponible en: https://pubmed.ncbi.nlm.nih.gov/37880536/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista de la Facultad de Medicina Humana
This work is licensed under a Creative Commons Attribution 4.0 International License.
